Salivary dysfuncTion After Radioiodine Treatment

CompletedOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

September 2, 2020

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Thyroid Cancer
Interventions
DRUG

Radioiodine

cancer therapy

Trial Locations (1)

75013

Pitié-Salpêtrière hospital, Paris

All Listed Sponsors
lead

Institut de Radioprotection et de Surete Nucleaire

OTHER_GOV

NCT04876287 - Salivary dysfuncTion After Radioiodine Treatment | Biotech Hunter | Biotech Hunter